BioSpace News Archive

Drug Development

Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001 Monotherapy Trial at the European Society for Medical Oncology Congress 2023

Hummingbird Bioscience announced presentation of positive clinical data for the dose escalation part of the HMBD-001 Phase I/IIa trial at the European Society for Medical Oncology Congress 2023.

October 23, 2023
·
6 min read
Drug Development

Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Solid Tumors and AML/HR-MDS, and Presents the Updated Development Plan for RVU120

Ryvu Therapeutics announced updated clinical Phase I data from RVU120 Phase I/II study in patients with relapsed/refractory metastatic or advanced solid tumors, presented at the European Society for Medical Oncology Congress 2023, taking place October 20-24 in Madrid, Spain.

October 23, 2023
·
8 min read
Biotech Bay

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer

Guardant Health, Inc. announced that initial results from the PEGASUS trial suggest liquid biopsy may be used in post-surgical clinical management to reduce unnecessary toxicity from chemotherapy and improve the response to standard chemotherapy regimens in patients with stage III or high-risk stage II colon cancer.

October 23, 2023
·
5 min read
Sunvozertinib Demonstrates Best-in-Class Potential as a First-Line Treatment for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer Patients

Dizal announced the latest research findings on the efficacy and safety of sunvozertinib in treatment-naïve patients with advanced or metastatic NSCLC with EGFR Exon20ins mutations at the 2023 European Society for Medical Oncology Congress.

October 23, 2023
·
5 min read
Policy

Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone

Insulet Corporation announced it has received FDA 510 clearance for the Omnipod 5 App for iPhone, making Insulet the first and only company to offer a tubeless automated insulin delivery system with full control from a compatible Android and iOS smartphone.

October 23, 2023
·
4 min read
Drug Development

IDEAYA Announces Top-Line Phase 2 Results at ESMO 2023 of Darovasertib and Crizotinib Combo in MUM, and Clinical Efficacy Updates for Neoadjuvant UM, GNAQ/11 Cutaneous Melanoma, and Synthetic Lethality Pipeline

IDEAYA Biosciences, Inc. announces clinical data presented at a proffered paper session of the European Society of Medical Oncology Congress 2023 from the company’s ongoing Phase 2 clinical trial evaluating darovasertib in combination with crizotinib in patients having metastatic uveal melanoma.

October 23, 2023
·
14 min read
Business

BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023

BioNTech SE will announce its financial results for the third quarter 2023 on Monday, November 6th, 2023.

October 23, 2023
·
2 min read
Genetown

Ayana Bio Launches Plant Cell Advantage™ Portfolio with Three New Health and Wellness Ingredients

Ayana Bio today announced the launch of its Plant Cell Advantage™ (PCA™) ingredient portfolio, including Dog Rose PCA™, Hedge Nettle PCA™, and Sage PCA™ as the latest additions in its offering of plant cell-cultivated health and wellness ingredients.

October 23, 2023
·
3 min read
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO

Oncolytics Biotech ® Inc. today announced the poster presentation of positive, updated results from the Phase 1/2 GOBLET study evaluating pelareorep-based combination therapy in patients with pancreatic ductal adenocarcinoma (PDAC) at the European Society for Medical Oncology meeting (ESMO 2023), taking place in Madrid, Spain.

October 23, 2023
·
9 min read
Drug Development

NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer Trial at ESMO 2023

NANOBIOTIX announced updated data from two presentations at the 2023 Annual Congress of the European Society for Medical Oncology.

October 23, 2023
·
11 min read